Anthropic announced a major expansion to its Claude platform, adding Claude for Healthcare to its existing expanded capabilities in Claude for Life Sciences. These new capabilities are meant to enable healthcare organizations, payers, researchers, or life sciences companies to make use of real-world scenarios to increase operational effectiveness as well as enhance scientific development.
Building on the strength of Claude’s latest model, Claude Opus 4.5, the company says Claude now delivers more accurate and contextually grounded responses for regulated medical and scientific tasks. These improvements, backed by internal performance evaluations, position Claude to better handle healthcare and life sciences use cases ranging from administrative workflow automation to clinical trial operations.
Introducing Claude for Healthcare
In launching Claude for Healthcare, Anthropic has expanded Claude’s utility for hospitals, insurers, healthcare technology companies, and individual consumers through HIPAA-ready integrations and secure connector tools. These connectors give Claude direct access to critical healthcare systems and datasets, enabling automated documentation, decision support, and enhanced administrative workflows.
Key data integrations now available with Claude include:
- Centers for Medicare & Medicaid Services (CMS) Coverage Database – supports prior authorization checks and policy lookups.
- International Classification of Diseases (ICD-10) – offers diagnostic and procedure code references to aid billing accuracy.
- National Provider Identifier (NPI) Registry – helps verify provider identities for credentialing and claims validation.
- PubMed biomedical library access – surfaces relevant research to clinicians and enterprise teams.
The platform also includes Agent Skills such as a FHIR development tool and a prior authorization review template, supporting interoperability and customizable process automation for healthcare developers and operators.
To help patients and consumers better understand their own health information, Claude now supports secure integrations with HealthEx and Function Health, plus beta rollouts for Apple Health and Android Health Connect on mobile apps. These tools enable users to summarize lab results, interpret trends, and prepare for conversations with clinicians while retaining strict privacy controls. Claude will not use users’ health data for model training.
Also Read: Insilico Medicine and Servier Forge Up to US$888 Million Multi-Year Oncology R&D Collaboration
Expanded Support for Life Sciences Workflows
Anthropic has also broadened Claude’s capabilities within the life sciences sector. The expanded toolset includes new connectors to major scientific platforms and research registries, enabling Claude to assist with clinical trial planning, regulatory operations, and early-stage discovery workflows.
New life sciences integrations include:
- Medidata – supplying clinical trial data and performance metrics.
- ClinicalTrials.gov – offering structured access to trial design and recruitment information.
- bioRxiv & medRxiv Preprint Servers – enabling access to the latest scientific research before formal publication.
- Open Targets & ChEMBL Databases – supporting therapeutic target identification and bioactive compound insights.
- ToolUniverse – a library of vetted scientific tools that enhances Claude’s research problem-solving capabilities.
Anthropic has also introduced Agent Skills tailored for scientific problem selection and protocol drafting including a sample skill for generating clinical trial protocols compliant with regulatory requirements.
Industry Adoption and Partner Perspectives
Anthropic focuses on the large adoption of Claude in the healthcare and life sciences industry. Its partners include Banner Health, Novo Nordisk, Genmab, Sanofi, and Flatiron Health, which see productivity enhancements through the use of Claude.
Customers have reported the creation of efficiencies in clinical documentation, regulatory planning, and data interpretation, which are associated with the rapid delivery of therapies and care.
